2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Updates on Pancreatic Cancer: mFOLFIRINOX vs. Gem/nab-P - Is There a Difference in Efficacy? Should We Consider Neoadjuvant FOLFIRINOX for Borderline Resectable Disease?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Heloisa Soares
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Heloisa Soares
1,641 views
September 16, 2020
Comments 0
Login to view comments.
Click here to Login
GI